Westpac Banking Corp’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$57.6K Hold
294
﹤0.01% 461
2025
Q4
$51K Sell
294
-567
-66% -$103K ﹤0.01% 447
2025
Q3
$164K Sell
861
-12
-1% -$2.13K 0.01% 366
2025
Q2
$157K Sell
873
-17,612
-95% -$3.06M 0.01% 370
2025
Q1
$3.13M Sell
18,485
-19
-0.1% -$3.12K 0.23% 110
2024
Q4
$2.79M Buy
18,504
+16,936
+1,080% +$2.63M 0.19% 127
2024
Q3
$243K Buy
1,568
+1,274
+433% +$190K 0.02% 352
2024
Q2
$40.2K Hold
294
﹤0.01% 436
2024
Q1
$39.1K Sell
294
-138
-32% -$17.9K ﹤0.01% 438
2023
Q4
$59.6K Sell
432
-5,602
-93% -$736K ﹤0.01% 415
2023
Q3
$735K Sell
6,034
-16,300
-73% -$2.17M 0.06% 263
2023
Q2
$3.14M Sell
22,334
-60,289
-73% -$8.31M 0.22% 125
2023
Q1
$11.7M Buy
82,623
+47,332
+134% +$6.77M 0.16% 169
2022
Q4
$5.52M Buy
35,291
+694
+2% +$99.7K 0.08% 303
2022
Q3
$4.24M Sell
34,597
-330
-0.9% -$43.5K 0.06% 367
2022
Q2
$4.64M Sell
34,927
-307
-0.9% -$41.8K 0.06% 387
2022
Q1
$4.82M Sell
35,234
-1,408
-4% -$196K 0.06% 394
2021
Q4
$6.34M Buy
36,642
+8,807
+32% +$1.34M 0.07% 358
2021
Q3
$4.04M Sell
27,835
-949
-3% -$139K 0.04% 452
2021
Q2
$3.8M Buy
28,784
+6,064
+27% +$794K 0.04% 483
2021
Q1
$2.92M Sell
22,720
-8,587
-27% -$1.06M 0.03% 494
2020
Q4
$3.73M Buy
31,307
+20,966
+203% +$2.56M 0.04% 458
2020
Q3
$1.18M Hold
10,341
0.02% 640
2020
Q2
$1.18M Sell
10,341
-2,100
-17% -$223K 0.02% 610
2020
Q1
$999K Buy
12,441
+1,832
+17% +$190K 0.02% 594
2019
Q4
$1.13M Buy
10,609
+2,100
+25% +$219K 0.01% 658
2019
Q3
$911K Hold
8,509
0.01% 669
2019
Q2
$866K Hold
8,509
0.01% 581
2019
Q1
$765K Sell
8,509
-58,090
-87% -$5.03M 0.01% 591
2018
Q4
$5.55M Buy
66,599
+2,800
+4% +$263K 0.09% 299
2018
Q3
$6.88M Buy
63,799
+1,386
+2% +$152K 0.12% 247
2018
Q2
$6.86M Sell
62,413
-3,496
-5% -$364K 0.13% 210
2018
Q1
$6.61M Buy
65,909
+13,600
+26% +$1.39M 0.13% 230
2017
Q4
$5.15M Sell
52,309
-8,900
-15% -$844K 0.12% 251
2017
Q3
$5.73M Sell
61,209
-3,574
-6% -$379K 0.13% 266
2017
Q2
$7.2M Buy
64,783
+7,919
+14% +$837K 0.16% 174
2017
Q1
$5.58M Sell
56,864
-9,750
-15% -$929K 0.04% 406
2016
Q4
$8.14M Sell
66,614
-14,917
-18% -$1.29M 0.08% 271
2016
Q3
$5.54M Sell
81,531
-92,118
-53% -$7.74M 0.06% 335
2016
Q2
$12.5M Sell
173,649
-32,806
-16% -$2.5M 0.14% 173
2016
Q1
$14.8M Buy
206,455
+27,907
+16% +$1.87M 0.16% 135
2015
Q4
$12.7M Buy
178,548
+75,334
+73% +$5.06M 0.14% 168
2015
Q3
$6.34M Sell
103,214
-14,253
-12% -$996K 0.07% 263
2015
Q2
$8.52M Buy
117,467
+104,137
+781% +$7.69M 0.08% 212
2015
Q1
$1.2M Buy
13,330
+270
+2% +$19.3K 0.01% 586
2014
Q4
$876K Sell
13,060
-98,229
-88% -$6.2M 0.01% 636
2014
Q3
$6.75M Buy
111,289
+600
+0.5% +$37K 0.07% 275
2014
Q2
$6.5M Sell
110,689
-22,145
-17% -$1.3M 0.06% 294
2014
Q1
$7.69M Hold
132,834
0.08% 241
2013
Q4
$7.11M Sell
132,834
-69,014
-34% -$4.09M 0.08% 256
2013
Q3
$12.5M Sell
201,848
-29,429
-13% -$1.76M 0.16% 156
2013
Q2
$13.1M Buy
+231,277
New +$13.8M 0.2% 136

Other funds holding DGX

Westpac Banking Corp's DGX Position: Q1 2026 in Review

Westpac Banking Corp held its Quest Diagnostics (DGX) position steady in Q1 2026 at 294 shares worth $57.6K. The position accounts for ﹤0.01% of the portfolio, ranked #461.

Westpac Banking Corp first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $14.8M in Q1 2016. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Westpac Banking Corp held 294 shares of Quest Diagnostics worth $57.6K as of Q1 2026.
  • Westpac Banking Corp left its Quest Diagnostics share count unchanged in Q1 2026.
  • Quest Diagnostics made up ﹤0.01% of Westpac Banking Corp's portfolio in Q1 2026, its #461 holding.
  • Westpac Banking Corp first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • Westpac Banking Corp's Quest Diagnostics position peaked at $14.8M in Q1 2016.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Westpac Banking Corp's 13F filing for Q1 2026, filed 12 May 2026.